The Department of Defense Peer Reviewed Cancer Research Program anticipates several funding opportunities for FY22.
The FY22 Defense Appropriations Act provides funding for the Peer Reviewed Cancer Research Program. The managing agent for the anticipated funding opportunities is the Congressionally Directed Medical Research Programs at the U.S. Army Medical Research and Development Command.
The FY22 PRCRP appropriation will provide funds for research into cancers not addressed in the other CDMRP cancer programs.
The FY22 PRCRP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website.
Pre-application and application deadlines will be available when the announcements are released.
To be considered for funding, applications for the FY22 PRCRP must address at least one of the FY22 PRCRP topic areas as directed by Congress. Research applications in the areas of breast, kidney, lung, prostate, pancreatic, ovarian, and rare cancer or melanoma are prohibited and will not be accepted.
The FY22 PRCRP topic areas are:
- Bladder cancer
- Blood cancers
- Brain cancer
- Colorectal cancer
- Endometrial cancer
- Esophageal cancer
- Germ cell cancers
- Liver cancer
- Lymphoma
- Mesothelioma
- Metastatic cancer
- Myeloma
- Neuroblastoma
- Pediatric, adolescent, and young adult cancers
- Pediatric brain tumors
- Sarcoma
- Stomach cancer
- Thyroid cancer
- Von Hippel-Lindau syndrome malignancies (excluding cancers of the kidney and pancreas)
The FY22 PRCRP requires all applications to address at least one of the following Military Health Focus Areas:
- Environmental/exposure risk factors associated with cancer
- Gaps in cancer research that may affect mission readiness:
- Gaps in cancer prevention, early detection/diagnosis, prognosis, and/or treatment that may affect the general population but have a particularly profound impact on the health and well-being of military Service Members, Veterans, and their beneficiaries
- Gaps in quality of life and/or survivorship that may affect the general population but have a particularly profound impact on the health and well-being of military Service Members, Veterans, and their beneficiaries
The PRCRP has developed a strategy to address multiple issues in cancer research over the spectrum of different cancer topics considered for funding. These overarching challenges are critical gaps in cancer research, care, and/or patient outcomes that, if addressed, will advance the mission readiness of U.S. military members affected by cancer and will improve quality of life by decreasing the burden of cancer on service members, their families, veterans, and the American public. The PRCRP Overarching Challenges can be found here.
Information about specific funding opportunities anticipated for FY22, including their award mechanisms, eligibility criteria, key elements, and funding amounts, can be found here.
